A Study to Evaluate the Safety of MEDI2338 in Subjects With Chronic Obstructive Pulmonary Disease

NCT01322594 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

BIOLOGICAL: MEDI2338
BIOLOGICAL: MEDI2338
BIOLOGICAL: MEDI2338
BIOLOGICAL: MEDI2338
BIOLOGICAL: MEDI2338
OTHER: Placebo

Sponsor

MedImmune LLC